Stay updated on Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page.

Latest updates to the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedRevision tag updated to v3.6.4, indicating the current build of the page. It replaces the previous v3.6.3.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a small patch or update to the page template or internal documentation. This appears to be an incremental improvement rather than a substantive content modification.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page's underlying software version was updated from v3.6.0 to v3.6.2, indicating a patch-level release.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page now shows recruitment has ended and adds guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) to aid user navigation. It also reflects a minor header formatting change to Intervention/Treatment and updates the revision tag from v3.5.5 to v3.6.0.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing Revision: v3.5.4, indicating an updated version of the page content. It is a metadata update and does not modify the study details.SummaryDifference0.0%

- Check86 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a newer version of the site software used to render the ClinicalTrials.gov page. This maintenance update does not modify the study details, eligibility criteria, or results presented on the page.SummaryDifference0.0%

Stay in the know with updates to Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page.